Brown Brothers Harriman & Co’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $743K | Buy |
8,635
+2,851
| +49% | +$250K | ﹤0.01% | 591 |
|
|
2026
Q1 | $523K | Buy |
5,784
+3,695
| +177% | +$339K | ﹤0.01% | 591 |
|
|
2025
Q4 | $188K | Sell |
2,089
-111
| -5% | -$10.5K | ﹤0.01% | 772 |
|
|
2025
Q3 | $217K | Buy |
2,200
+419
| +24% | +$41.5K | ﹤0.01% | 671 |
|
|
2025
Q2 | $162K | Buy |
1,781
+305
| +21% | +$29.5K | ﹤0.01% | 684 |
|
|
2025
Q1 | $167K | Buy |
1,476
+58
| +4% | +$6.21K | ﹤0.01% | 597 |
|
|
2024
Q4 | $150K | Sell |
1,418
-388
| -21% | -$41.6K | ﹤0.01% | 634 |
|
|
2024
Q3 | $195K | Buy |
1,806
+195
| +12% | +$21.3K | ﹤0.01% | 584 |
|
|
2024
Q2 | $175K | Sell |
1,611
-65
| -4% | -$7.66K | ﹤0.01% | 562 |
|
|
2024
Q1 | $221K | Buy |
1,676
+199
| +13% | +$24.9K | ﹤0.01% | 505 |
|
|
2023
Q4 | $180K | Sell |
1,477
-121
| -8% | -$13.5K | ﹤0.01% | 509 |
|
|
2023
Q3 | $179K | Sell |
1,598
-465
| -23% | -$59.1K | ﹤0.01% | 498 |
|
|
2023
Q2 | $300K | Buy |
2,063
+80
| +4% | +$10.9K | ﹤0.01% | 406 |
|
|
2023
Q1 | $256K | Buy |
1,983
+44
| +2% | +$5.52K | ﹤0.01% | 441 |
|
|
2022
Q4 | $247K | Buy |
1,939
+24
| +1% | +$2.79K | ﹤0.01% | 426 |
|
|
2022
Q3 | $200K | Buy |
1,915
+248
| +15% | +$27.2K | ﹤0.01% | 464 |
|
|
2022
Q2 | $175K | Sell |
1,667
-612
| -27% | -$72.6K | ﹤0.01% | 489 |
|
|
2022
Q1 | $291K | Sell |
2,279
-240
| -10% | -$28.9K | ﹤0.01% | 433 |
|
|
2021
Q4 | $311 | Buy |
2,519
+176
| +8% | +$23K | ﹤0.01% | 409 |
|
|
2021
Q3 | $333 | Sell |
2,343
-138
| -6% | -$20.3K | ﹤0.01% | 375 |
|
|
2021
Q2 | $387 | Buy |
2,481
+72
| +3% | +$11.7K | ﹤0.01% | 346 |
|
|
2021
Q1 | $374 | Buy |
2,409
+258
| +12% | +$40K | ﹤0.01% | 322 |
|
|
2020
Q4 | $322K | Buy |
2,151
+435
| +25% | +$61.4K | ﹤0.01% | 361 |
|
|
2020
Q3 | $227K | Sell |
1,716
-167
| -9% | -$21.8K | ﹤0.01% | 364 |
|
|
2020
Q2 | $218K | Buy |
1,883
+1,560
| +483% | +$180K | ﹤0.01% | 364 |
|
|
2020
Q1 | $32K | Sell |
323
-1,386
| -81% | -$182K | ﹤0.01% | 577 |
|
|
2019
Q4 | $248K | Buy |
1,709
+1,305
| +323% | +$180K | ﹤0.01% | 420 |
|
|
2019
Q3 | $54K | Buy |
404
+26
| +7% | +$3.36K | ﹤0.01% | 631 |
|
|
2019
Q2 | $43K | Buy |
378
+103
| +37% | +$12.1K | ﹤0.01% | 613 |
|
|
2019
Q1 | $34K | Sell |
275
-46
| -14% | -$5.23K | ﹤0.01% | 647 |
|
|
2018
Q4 | $32K | Buy |
321
+100
| +45% | +$11.2K | ﹤0.01% | 562 |
|
|
2018
Q3 | $28K | Hold |
221
| – | – | ﹤0.01% | 578 |
|
|
2018
Q2 | $24K | Hold |
221
| – | – | ﹤0.01% | 573 |
|
|
2018
Q1 | $23K | Sell |
221
-49
| -18% | -$5.69K | ﹤0.01% | 567 |
|
|
2017
Q4 | $32K | Sell |
270
-41
| -13% | -$4.64K | ﹤0.01% | 572 |
|
|
2017
Q3 | $35K | Hold |
311
| – | – | ﹤0.01% | 514 |
|
|
2017
Q2 | $39K | Sell |
311
-505
| -62% | -$59.9K | ﹤0.01% | 510 |
|
|
2017
Q1 | $97K | Buy |
816
+100
| +14% | +$11.3K | ﹤0.01% | 414 |
|
|
2016
Q4 | $72K | Buy |
716
+412
| +136% | +$44.2K | ﹤0.01% | 436 |
|
|
2016
Q3 | $38K | Buy |
304
+149
| +96% | +$18.4K | ﹤0.01% | 471 |
|
|
2016
Q2 | $18K | Buy |
155
+78
| +101% | +$8.83K | ﹤0.01% | 568 |
|
|
2016
Q1 | $8K | Hold |
77
| – | – | ﹤0.01% | 580 |
|
|
2015
Q4 | $8K | Hold |
77
| – | – | ﹤0.01% | 624 |
|
|
2015
Q3 | $7K | Sell |
77
-1,262
| -94% | -$127K | ﹤0.01% | 695 |
|
|
2015
Q2 | $142K | Sell |
1,339
-241
| -15% | -$26.7K | ﹤0.01% | 373 |
|
|
2015
Q1 | $180K | Hold |
1,580
| – | – | ﹤0.01% | 354 |
|
|
2014
Q4 | $174K | Sell |
1,580
-30
| -2% | -$3.16K | ﹤0.01% | 369 |
|
|
2014
Q3 | $157K | Buy |
1,610
+1,030
| +178% | +$101K | ﹤0.01% | 378 |
|
|
2014
Q2 | $58K | Sell |
580
-736
| -56% | -$71.8K | ﹤0.01% | 491 |
|
|
2014
Q1 | $121K | Sell |
1,316
-479
| -27% | -$44.1K | ﹤0.01% | 398 |
|
|
2013
Q4 | $162K | Buy |
1,795
+1,215
| +209% | +$105K | ﹤0.01% | 339 |
|
|
2013
Q3 | $46K | Sell |
580
-154
| -21% | -$12.1K | ﹤0.01% | 480 |
|
|
2013
Q2 | $53K | Buy |
+734
| New | +$54.9K | ﹤0.01% | 526 |
|
Other funds holding ZBH
Brown Brothers Harriman & Co's ZBH Position: Q2 2026 in Review
Brown Brothers Harriman & Co increased its Zimmer Biomet (ZBH) stake by 49% in Q2 2026, buying an estimated $250K and bringing the position to 8,635 shares worth $743K. The position accounts for ﹤0.01% of the portfolio, ranked #591.
Brown Brothers Harriman & Co first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Brown Brothers Harriman & Co held 8,635 shares of Zimmer Biomet worth $743K as of Q2 2026.
- Brown Brothers Harriman & Co bought 2,851 Zimmer Biomet shares in Q2 2026, an estimated $250K.
- Zimmer Biomet made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #591 holding.
- Brown Brothers Harriman & Co first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.